Abstract:The objectives of this study were to investigate the effects of the CRISPR/Cas9 system mediated by the HPV pseudotype virus on SiHa cytobiology behavior by cutting the HPV16 E6 gene selectively and to explore the role of this system in the treatment of cervical cancer. After designing specific gRNA sequences targeting HPV16 E6, generating hCas9-EGFP and E6-gRNA-RFP plasmids, and preparing the pseudovirus of HPV16 carrying E6-gRNA and Cas9 plasmids, we determined the titer of the pseudotype virus using the TCID50 method. We obtained the pseudotype virus of HPV16 carrying E6-gRNA and Cas9 plasmids to transfect cervical cancer SiHa cells. Experimental subjects were divided into control group, empty virus group, E6-gRNA transfected group, Cas9 transfected group and Cas9+E6-gRNA transfected group. The molecular size of the cutting sequence was detected using the T7E1 enzyme digestion method and agarose gel electrophoresis, and the cleavage function of CRISPR/Cas9 on the E6 gene was determined at the same time. RT-PCR and Western blotting were performed to detect the mRNA and protein expression levels of E6 in all the groups; the Transwell cell migration assay was performed to detect the cell migration ability and metastasis in all groups. Heterotopic transplantation tumors were incorporated into mice and were used to investigate the effects of the CRISPR/Cas9 system mediated by the HPV pseudovirus on the tumorigenic ability of SiHa cells by selectively cutting HPV16 E6. The HPV16 pseudotype virus carrying E6-gRNA and Cas9 plasmids could successfully infect SiHa cells, and there were two cutting zones in the Cas9+E6-gRNA transfected group. However, the empty virus group, E6-gRNA transfected group and Cas9 transfected group had no corresponding zone. Compared with those in the control group, the empty virus group, E6-gRNA transfected group and Cas9 transfected group, the mRNA and protein expression levels of E6 in SiHa cells were downregulated in the Cas9+E6-gRNA transfected group (P<0.01). In addition, the proliferation and migration abilities of SiHa cells were significantly inhibited (P<0.01). There were no significant differences among the other groups. In contrast to the control group, the HPV pseudotype virus carrying E6-gRNA and Cas9 plasmids could significantly delay the growth of tumor cells of the ectopic tumor transplantation model (P<0.01). The CRISPR/Cas9 system mediated by the HPV pseudotype virus to knockout E6 gene expression exhibited a clear inhibitory effect on the biological function of SiHa cells, which indicated that knocking out the E6 gene using the CRISPR/Cas9 system mediated by the HPV pseudotype virus had a potential effect of eliminating HPV infection and inhibiting the growth of HPV-related tumors. Taken together, these findings provide insight into a new treatment strategy for the prevention and treatment of hr-HPV infected disease, particularly in HPV-related tumors.

Adenovirus Vector Mediated HPV 16E7 Silencing and Its Effect on Cervical Cancer CaSki Cells

Silencing of HPV11ET gene expression by different RNA interference technology

Reversal of the Malignant Phenotype of Cervical Cancer CaSki Cells Through Adeno-Associated Virus–Mediated Delivery of HPV16 E7 Antisense RNA

Advances of RNAi in HPV16 E6/E7 of Cervical Cancer

Selective Silencing of Viral Gene Expression in HPV6bE6-positive Cell Line Treated with Specific siRNA

Biological feature changes of HPV16 positive cervical carcinoma cell resulting from expression inhibition of oncogene E7 by specific siRNA

Specific siRNA inhibits the expression of HPV16 E7 gene in cervical carcinoma

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Specific siRNA inhibited the expression of hguman papillomavirus type 16 E6 gene in HPV16-poistive cervical carcinoma cell

Role of RhoC-siRNA Expression Vector on Growth Velocity and Invasiveness of Hepatoma Carcinoma Cells

Transcriptional Gene Silencing of HPV16 E6/E7 Induces Growth Inhibition Via Apoptosis in Vitro and in Vivo

Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells

Inhibition of cervical cancer cell growth invitro and invivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6and E7oncogenes

Enhanced Immunotherapeutic Effect of Modified HPV16 E7-pulsed Dendritic Cell Vaccine by an Adeno-Shrna-socs1 Virus

Effects of Human Papillomavirus 16 E6-specific Short Hairpin RNA on Cervical Carcinoma Cell

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells

RNA Interference Silences the Human Papillomavirus 6b/11 Early Gene E7 in Vitro and in Vivo.

Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells

[Downregulation of HER2 by Adenovirus-Mediated RNA Interference and Its Inhibitory Effect on Growth of SKBR3 Breast Cancer Cell].

Application of Fluorescent Quantitative PCR in RNA Interference Inhibiting Cervical Cancer

Mir-2861 Acts As a Tumor Suppressor Via Targeting EGFR/AKT2/CCND1 Pathway in Cervical Cancer Induced by Human Papillomavirus Virus 16 E6